Multiple Nevi
Showing 76 - 100 of >10,000
Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,
Active, not recruiting
- Relapsing Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Ocrelizumab IV
- +5 more
-
Tampa, Florida
- +46 more
Jan 13, 2023
Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Jul 31, 2023
Plasma Cell Myeloma Trial in United States (Ixazomib Citrate, Lenalidomide, Placebo Administration)
Recruiting
- Plasma Cell Myeloma
- Ixazomib Citrate
- +4 more
-
Phoenix, Arizona
- +221 more
Jan 28, 2023
Back Pain Trial (Pilates Exercise, Mckenzie Exercise)
Not yet recruiting
- Back Pain
- Pilates Exercise
- Mckenzie Exercise
- (no location specified)
Jun 1, 2023
Healthy Participants Trial in Glendale (AZD2389, Placebo)
Not yet recruiting
- Healthy Participants
- AZD2389
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 14, 2023
Healthy Participants Trial in Glendale, Brooklyn (AZD4144 Part A, AZD4144 Part B, Placebo Part A)
Not yet recruiting
- Healthy Participants
- AZD4144 Part A
- +3 more
-
Glendale, California
- +1 more
Nov 3, 2023
Healthy Participants Trial in Neuss (NNC0113-6856, Placebo)
Not yet recruiting
- Healthy Participants
- NNC0113-6856
- Placebo
-
Neuss, GermanyNovo Nordisk Investigational Site
Sep 29, 2023
Multiple Sclerosis Trial (plantar sensitivity training, aerobic exercise training)
Not yet recruiting
- Multiple Sclerosis
- plantar sensitivity training
- aerobic exercise training
- (no location specified)
Jul 13, 2023
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)
Not yet recruiting
- Myasthenia Gravis
- +3 more
- CNP-106
- Placebo
-
Chicago, IllinoisResearch Site
Oct 30, 2023
Advanced Solid Tumor Trial in Hangzhou (BR101)
Recruiting
- Advanced Solid Tumor
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University Medical Co
Aug 14, 2023
Neovascular Age-related Macular Degeneration Trial in United States (OLX10212 is a cell penetrating asymmetric small
Recruiting
- Neovascular Age-related Macular Degeneration
- OLX10212 is a cell penetrating asymmetric small interference RNA (cp-asiRNA)
-
Santa Maria, California
- +4 more
Jan 10, 2023
Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)
Not yet recruiting
- Multiple Sclerosis
- Progressive Multiple Sclerosis
- Nicotinamid riboside
- Placebo
-
Bergen, NorwayHaukeland University Hospital
Feb 22, 2023
High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,
Recruiting
- High-risk Smoldering Multiple Myeloma
- +2 more
- Teclistamab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Aug 11, 2022
Multiple Sclerosis Trial in Malatya (Cognitive function, cognitive reserve, functional capacity, reaction time, strength,
Completed
- Multiple Sclerosis
- Cognitive function, cognitive reserve, functional capacity, reaction time, strength, fatigue, depression and general health assessment
-
Malatya, TurkeyInonu University
Oct 10, 2023
Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer
Completed
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Myeloma Coach or CLL Coach Mobile App
- Springboard Beyond Cancer informational website
-
Durham, North CarolinaDuke University
Jun 23, 2023
Potassium Measurement Trial (Device: Self testing Potassium device)
Not yet recruiting
- Potassium Measurement
- Device: Self testing Potassium device
- (no location specified)
Jul 27, 2023
Healthy, Drug-Drug Interaction Trial in Shanghai (JMKX000623, Metformin)
Active, not recruiting
- Healthy
- Drug-Drug Interaction
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Sep 30, 2023
Rheumatoid Arthritis Trial in Chengdu (TollB-001 tablets, TollB-001 )
Recruiting
- Rheumatoid Arthritis
- TollB-001 tablets
- TollB-001 placebo
-
Chengdu, Sichuan, ChinaChengdu Fifth People's Hospital
Oct 22, 2023
Healthy Subject Trial in Chengdu (GS3-007 oral liquid)
Not yet recruiting
- Healthy Subject
- GS3-007 oral liquid
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023
Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)
Active, not recruiting
- Cocaine Use Disorder
- +2 more
- TMP-301
- Placebo
-
Overland Park, KansasAltasciences
Aug 29, 2023
Healthy Volunteers Trial in Austin (Treprostinil Palmitil Inhalation Powder, Placebo)
Completed
- Healthy Volunteers
- Treprostinil Palmitil Inhalation Powder
- Placebo
-
Austin, TexasUSA001
Oct 16, 2023